Advertisement

RainDance Technologies Inc. announced a service partner program for its growing base of research customers who are developing next-generation sequencing-based genetic testing panels to identify and characterize inherited diseases, cancers, and other human health conditions in research projects. Through this new program, customers have expanded access to RainDance’s ThunderStorm target enrichment solution, custom gene panel manufacturing capabilities, and technical support services.

RainDance-manufactured gene panels provide researchers with a way to use single-plex PCR in picodroplets to target specific human genes or regions of interest. The ability to put single PCR reactions in droplets enables highly multiplexed panels with the sensitivity of single tests in a workflow that eliminates the need for the costly and time-consuming, repetitive testing of single biomarkers.

Among the first service provider partners to participate in the new program are Ambry Genetics, Emory Genetics Laboratory and Greenwood Genetic Center. Collectively, these leading research laboratories have developed more than 20 gene panels manufactured by RainDance for use in research to investigate colon cancer, cardiomyopathy, ciliopathies, congenital muscular dystrophy, epilepsy, hearing loss, and autism spectrum disorders, among many others.

The ThunderStorm System is a fully automated, targeted sequencing solution for research use only that enables the comprehensive interrogation and accurate classification of all variations contained in any region of the genome. With walk-away capabilities for automatically processing up to 96 samples per run, the ThunderStorm System offers the industry’s highest on-target reads with lower costs and hands-on time when compared to current enrichment methods. Each panel is performed on HeatWave ThunderStorm Chips developed by RainDance in collaboration with Sony DADC.

The RainDance Service Partner Program will allow the company to deepen ongoing collaborations with its customers and raise awareness of how RainDance’s technology allows them to apply next-generation sequencing to a variety of diseases.

RainDance Technologies Inc.

Advertisement
Advertisement